Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FTKXY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,553
Award facts
- Contract value 100% obligated
- $15,553.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,553.20 by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Botox 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026, positioning the vendor as a key supplier within the federal pharmaceutical supply chain.
The DLA utilizes its IDC with DMS Pharmaceutical Group to procure a comprehensive range of pharmaceutical products supporting medical supply requirements across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established portfolio demonstrates consistent success in delivering specialized pharmaceutical items including prescription medications, biologics, and medical consumables to federal agencies. The Botox delivery under this order supports the DLA's broader mission to maintain adequate inventory of pharmaceutical products for military health systems and represents routine execution of the broader indefinite delivery vehicle that enables flexible procurement of medical supplies as needed by the department.
Quick answers
Who was awarded contract SPE2DB25FTKXY?
SPE2DB25FTKXY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FTKXY worth?
The government has obligated $15,553 on SPE2DB25FTKXY.
Is contract SPE2DB25FTKXY an order under another contract?
Yes. SPE2DB25FTKXY is a delivery order under SPE2DB25D9756, an indefinite delivery contract.
Was contract SPE2DB25FTKXY competed?
The extent of competition for SPE2DB25FTKXY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award